FDA Import Refusal 799-1289571-9/11/1 — STEDMAN PHARMACEUTICALS
The FDA refused shipment 799-1289571-9/11/1 from STEDMAN PHARMACEUTICALS (India) on Apr 26, 2019. The refused product falls under Drugs and Biologics — DICLOFENAC SODIUM (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 3 other import refusals on record.
Refusal Details
- Date
- Apr 26, 2019
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62GAJ18 DICLOFENAC SODIUM (ANTI-INFLAMMATORY)
- Charges
- 75